Strategic Financial Services, Inc, Edwards Lifesciences Corp Transaction History

Strategic Financial Services, Inc,

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $151,202 - $224,215	-1,748 Closed	0 $0
Q1 2022 Apr 26, 2022	SELL	$101.96 - $128.34 $2,549 - $3,208	-25 Reduced 1.41%	1,748 $206,000
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $51,455 - $61,375	-500 Reduced 22.0%	1,773 $201,000
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $190,568 - $238,119	2,273 New	2,273 $235,000
Q1 2021 May 06, 2021	SELL	$78.68 - $90.67 $187,887 - $216,519	-2,388 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$71.69 - $91.23 $171,195 - $217,857	2,388 New	2,388 $218,000

1,350

457M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Strategic Financial Services, Inc,, based on Form 13F filings with the SEC.

Stay updated on Strategic Financial Services, Inc, with notifications on news.